| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 6, 2236-2243, Copyright © 1992 by Endocrine Society
ARTICLES |
AM Stevens and LY Yu-Lee
Department of Microbiology, Baylor College of Medicine, Houston, Texas 77030.
PRL induces quiescent Nb2 rat T-lymphoma cells to undergo mitogenesis. Upon PRL stimulation, the transcription factor interferon regulatory factor-1 (IRF-1) is induced as a novel T-cell activation gene in Nb2 cells. Surprisingly, IRF-1 is expressed twice during a single PRL- induced growth cycle: first during the early G1 phase, in an immediate transient peak from 15 min to 2 h, and second during the G1/S phase transition, in a broader peak beginning at 8 h. The unusual biphasic expression of IRF-1 mRNA is accompanied both times by de novo IRF-1 protein synthesis. However, the rate of IRF-1 protein turnover appears to be different in G1 and S phases. IRF-1 protein expressed in G1 exhibits a half-life of about 25 min, whereas in the S phase, the half- life is about 60 min. By washing out PRL at various times during G1, we found a direct correlation among the length of PRL exposure, the second peak of IRF-1 mRNA expression, and DNA synthesis. Our data suggest that PRL and one putative nuclear mediator, IRF-1, may be important in two distinct phases of the cell cycle: first in cell cycle activation, and then in S phase progression.
This article has been cited by other articles:
 |
|
 |
|
  S.-h. Lee, M. Nishino, T. Mazumdar, G. E. Garcia, M. Galfione, F. L. Lee, C. L. Lee, A. Liang, J. Kim, L. Feng, et al. 16-kDa Prolactin Down-Regulates Inducible Nitric Oxide Synthase Expression through Inhibition of the Signal Transducer and Activator of Transcription 1/IFN Regulatory Factor-1 Pathway Cancer Res., September 1, 2005; 65(17): 7984 - 7992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Lin, X. Zhu, F. L. Mclntee, H. Xiao, J. Zhang, M. Fu, and Y. E. Chen Interferon Regulatory Factor-1 Mediates PPAR{gamma}-Induced Apoptosis in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 257 - 263. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Tseng and H. H. Zhu Progestin, Estrogen, and Insulin-like Growth Factor-I Stimulate the Prolactin Receptor mRNA in Human Endometrial Stromal Cells Reproductive Sciences, May 1, 1998; 5(3): 149 - 155. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Luo and L.-y. Yu-Lee Transcriptional Inhibition by Stat5. DIFFERENTIAL ACTIVITIES AT GROWTH-RELATED VERSUS DIFFERENTIATION-SPECIFIC PROMOTERS J. Biol. Chem., October 24, 1997; 272(43): 26841 - 26849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-f. Wang, K. D. O’Neal, and L.-y. Yu-Lee Multiple Prolactin (PRL) Receptor Cytoplasmic Residues and Stat1 Mediate PRL Signaling to the Interferon Regulatory Factor-1 Promoter Mol. Endocrinol., August 1, 1997; 11(9): 1353 - 1364. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Han, D. Watling, N. C. Rogers, and G. R. Stark JAK2 and STAT5, but not JAK1 and STAT1, Are Required for Prolactin-Induced {beta}-Lactoglobulin Transcription Mol. Endocrinol., July 1, 1997; 11(8): 1180 - 1188. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
